ATE303805T1 - Zusammensetzung gegen erhöhung oder zur herabsetzung des blutzuckerspiegels - Google Patents

Zusammensetzung gegen erhöhung oder zur herabsetzung des blutzuckerspiegels

Info

Publication number
ATE303805T1
ATE303805T1 AT99123173T AT99123173T ATE303805T1 AT E303805 T1 ATE303805 T1 AT E303805T1 AT 99123173 T AT99123173 T AT 99123173T AT 99123173 T AT99123173 T AT 99123173T AT E303805 T1 ATE303805 T1 AT E303805T1
Authority
AT
Austria
Prior art keywords
composition
increase
blood sugar
sugar levels
decrease blood
Prior art date
Application number
AT99123173T
Other languages
English (en)
Inventor
Futoshi Matsuyama
Original Assignee
Matsuyama Futoshi C O Use Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18405294&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE303805(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Matsuyama Futoshi C O Use Tech filed Critical Matsuyama Futoshi C O Use Tech
Application granted granted Critical
Publication of ATE303805T1 publication Critical patent/ATE303805T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
AT99123173T 1998-12-09 1999-11-23 Zusammensetzung gegen erhöhung oder zur herabsetzung des blutzuckerspiegels ATE303805T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10349667A JP2000169384A (ja) 1998-12-09 1998-12-09 血糖値上昇抑制乃至下降用組成物

Publications (1)

Publication Number Publication Date
ATE303805T1 true ATE303805T1 (de) 2005-09-15

Family

ID=18405294

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99123173T ATE303805T1 (de) 1998-12-09 1999-11-23 Zusammensetzung gegen erhöhung oder zur herabsetzung des blutzuckerspiegels

Country Status (7)

Country Link
US (3) US6485760B2 (de)
EP (1) EP1022022B1 (de)
JP (1) JP2000169384A (de)
AT (1) ATE303805T1 (de)
DE (1) DE69927125T2 (de)
DK (1) DK1022022T3 (de)
ES (1) ES2245812T3 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU777789B2 (en) * 1999-05-25 2004-10-28 Use.Techno Corporation Liquid composition to be vaporized for inhibiting increase in blood sugar level, vaporizer for the same and use of the same
US7713546B1 (en) * 2001-04-03 2010-05-11 Soft Gel Technologies, Inc. Corosolic acid formulation and its application for weight-loss management and blood sugar balance
AU2002219858A1 (en) * 2000-11-28 2002-06-11 Avon Products Inc. Anti-aging cosmetic composition and method of application
JP2002255837A (ja) * 2001-03-01 2002-09-11 Mikimoto Pharmaceut Co Ltd アルドースレダクターゼ阻害剤
CA2458782A1 (en) * 2001-08-31 2003-03-06 Ohio University Compositions and methods for treating subjects with hyperglycemia
US6908632B1 (en) * 2002-04-19 2005-06-21 Pharmanex, Llc Blood glucose modulating compositions and methods
JP4094332B2 (ja) * 2002-04-23 2008-06-04 丸善製薬株式会社 水分散性又は水溶解性のバナバ葉抽出物組成物
JP2005029570A (ja) 2003-06-16 2005-02-03 Tokiwa Shokubutsu Kagaku Kenkyusho:Kk コロソリン酸の製造方法
JP2005126414A (ja) * 2003-09-11 2005-05-19 Kiyotoshi Oshiro 吸収を高める生薬成分含有組成物及びその製造方法。
US20050142270A1 (en) * 2003-09-22 2005-06-30 Use- Techno Corporation Functional sweetener
US20050137259A1 (en) * 2003-09-22 2005-06-23 Use- Techno Corporation Insulin secretion potentiator
US20050143464A1 (en) * 2003-09-22 2005-06-30 Use-Techno Corporation Insulin secretion potentiator
US20070093552A1 (en) * 2003-09-22 2007-04-26 Futoshi Matsuyama Early insulin secretion stimulator
US7125571B2 (en) 2003-11-25 2006-10-24 D & E Pharmaceuticals, Inc. Herbal formulation
US20050267055A1 (en) * 2003-12-26 2005-12-01 Use-Techno Corporation Agent for improvement of glucose tolerance
JPWO2005063228A1 (ja) * 2003-12-26 2007-07-19 株式会社ユース・テクノコーポレーション 耐糖能改善剤
US20050186269A1 (en) * 2004-02-25 2005-08-25 Udell Ronald G. Stabilized feverfew formulations
JP4922550B2 (ja) * 2004-03-16 2012-04-25 株式会社東洋新薬 コロソリン酸高含有バナバ葉抽出物の製造方法
JP4688795B2 (ja) * 2004-04-15 2011-05-25 三栄源エフ・エフ・アイ株式会社 バナバ抽出物の調製方法
JP2005350453A (ja) * 2004-05-14 2005-12-22 Toyo Shinyaku:Kk バナバ葉の水難溶性成分
WO2006012015A2 (en) * 2004-06-29 2006-02-02 Oregon Health And Science University Methods and compositions for nerve regeneration
US20060051435A1 (en) * 2004-08-19 2006-03-09 Udell Ronald G Nutritional supplement for body fat reduction
CN1303096C (zh) * 2004-10-12 2007-03-07 中国药科大学 科罗索酸和山楂酸的制备方法
WO2006054370A1 (en) * 2004-11-16 2006-05-26 Use-Techno Corporation Gluconeogenesis inhibiting agent
US7574353B2 (en) * 2004-11-18 2009-08-11 Lsi Logic Corporation Transmit/receive data paths for voice-over-internet (VoIP) communication systems
JP2008525497A (ja) * 2004-12-22 2008-07-17 ルネサンス ハーブス インコーポレイテッド オオバナサルスベリ植物に由来する医薬組成物、治療組成物、及び食品組成物
EP1859774A4 (de) * 2005-02-22 2009-09-30 Maruzen Pharm Co Ltd Haarkosmetikum
KR100693400B1 (ko) * 2005-06-30 2007-03-09 주식회사 삼양제넥스 식물 세포 현탁 배양에 의한 코로솔릭산의 제조방법
KR100697184B1 (ko) 2006-01-06 2007-03-21 주식회사 농협고려인삼 인삼과 상엽과 바나바엽을 주재로 한 혈당강하용 기능성 식품 및 그 제조방법
US20070166321A1 (en) * 2006-01-13 2007-07-19 Bryant Villeponteau Compositions and Methods for Reducing Cholesterol and Inflammation
WO2007094497A1 (ja) * 2006-02-17 2007-08-23 Use-Techno Corporation メタボリックシンドローム改善剤
WO2008060553A1 (en) 2006-11-14 2008-05-22 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Transcatheter coronary sinus mitral valve annuloplasty procedure and coronary artery and myocardial protection device
US9943409B2 (en) 2006-11-14 2018-04-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Transcatheter coronary sinus mitral valve annuloplasty procedure and coronary artery and myocardial protection device
US7416750B1 (en) 2007-02-26 2008-08-26 Nbty, Inc. Composition to provide maintenance and nutritional support in glycemic control deficits
US20080268039A1 (en) * 2007-03-06 2008-10-30 Soft Gel Technologies, Inc. Loquat compositions
JP2013010715A (ja) * 2011-06-29 2013-01-17 Nippon Flour Mills Co Ltd う蝕予防剤、歯周病予防剤及び口腔用組成物
US12544227B2 (en) 2016-05-06 2026-02-10 Transmural Systems Llc Annuloplasty procedures, related devices and methods
US11007059B2 (en) 2016-05-06 2021-05-18 Transmural Systems Llc Annuloplasty procedures, related devices and methods
KR102654995B1 (ko) 2016-05-06 2024-04-04 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 고리성형술 절차들, 관련된 기기들 및 방법들
US11980545B2 (en) 2016-05-06 2024-05-14 Transmural Systems Llc Annuloplasty procedures, related devices and methods
US11039923B2 (en) 2016-05-06 2021-06-22 Transmural Systems Llc Annuloplasty procedures, related devices and methods
EP3672532B1 (de) 2017-08-26 2022-08-03 Transmural Systems LLC Implantierbares herzschrittmachersystem

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4544550A (en) * 1982-10-05 1985-10-01 Rodolfo Almanzor Y Method for the treatment of diabetes
JPH05310587A (ja) 1992-03-11 1993-11-22 Itouen:Kk バナバ葉抽出物と使用方法並びに抗糖尿病剤
JP3507116B2 (ja) * 1994-02-18 2004-03-15 株式会社 伊藤園 コレステロール上昇抑制作用剤
JP3507115B2 (ja) * 1994-02-18 2004-03-15 株式会社 伊藤園 バナバ葉抽出物と抗糖尿病剤

Also Published As

Publication number Publication date
US20030008025A1 (en) 2003-01-09
DE69927125D1 (de) 2005-10-13
ES2245812T3 (es) 2006-01-16
EP1022022A1 (de) 2000-07-26
EP1022022B1 (de) 2005-09-07
JP2000169384A (ja) 2000-06-20
US20010006941A1 (en) 2001-07-05
US20010000474A1 (en) 2001-04-26
DK1022022T3 (da) 2006-01-09
US6716459B2 (en) 2004-04-06
DE69927125T2 (de) 2006-05-18
US6485760B2 (en) 2002-11-26

Similar Documents

Publication Publication Date Title
DE69927125D1 (de) Zusammensetzung gegen Erhöhung oder zur Herabsetzung des Blutzuckerspiegels
ATE321462T1 (de) Verbesserte pädiatrische zusammensetzung und verfahren zur ernährung und verbesserung der toleranz
CA2417089A1 (en) Palatable oral coenzyme q liquid
JP2003513039A5 (de)
TW429145B (en) Pharmaceutical composition for treating schizophrenia, tardive dyskinesia, depression, and alzheimer's disease comprising EPA/SA
ATE395916T1 (de) Orale methylphenidat-formulierungen mit kontrollierter/veränderter freisetzung
SE9803710L (sv) Användning av vissa substanser för behandling av nervrotsskador
CA2201264A1 (en) Immediate release ph-independent solid dosage form of cisapride
WO2003051380A3 (en) Compositions containeing curcuma extracts for the treatment of neurocerebrovascular disorders
CA2271162A1 (en) Stearidonic acid compositions and uses thereof
UA90668C2 (ru) Состав для лечения хронической венозной недостаточности, который содержит водный экстракт листьев красного винограда и противовоспалительное средство
ATE303729T1 (de) Käsearoma
ES2077703T3 (es) Inhibidores de la glucosiltransferasa, asi como metodos para la prevencion de la caries dental y alimentos anticaries que utilizan estos inhibidores.
WO2000064276A3 (en) Enriched spreads
WO2002005801A3 (en) Compositions containing diacyltartaric salts of (e)-metanicotine
EP1129711A3 (de) Pinolensäure gegen Diabetes
ATE493134T1 (de) Gefriergetrocknetes präparat mit methylcobalamin und verfahren zu seiner herstellung
PT100668A (pt) Composicao farmaceutica compreendendo extractos alcoolicos de corydalis e eschsoltzia para utilizacao no tratamento de estados de agitacao e doencas dos nervos
EP1269991A3 (de) Topische Zusammensetzung die Ethyllinoleat und/oder Triethylzitrat mit Synergisten
DE60107441D1 (de) Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von dysphorie
DE69501183D1 (de) Feste orale pharmazeutische Zubereitung mit Gemfibrozil als aktiver Inhaltsstoff und Verfahren zur Herstellung
Fallahinejad Ghajari et al. Comparing the erosive effect of Iranian soft drinks with standard samples A Calcium ion analysis
ATE241693T1 (de) Neues anethanol enthaltend klares gegebenfalls alkoholisches getränk und trübes verdünntes getränk hergestellt durch verdünnung
PL378344A1 (pl) Sposób usprawniania przepływu krwi
WO2005023216A3 (de) Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulans äure

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties